Quirin Graf Adelmann was born near Munich and grew up bilingually in France and Germany. After studying law at Humboldt University in Berlin, he worked as an employed managing director in the automotive and real estate sectors before becoming an independent entrepreneur in 2010.
Quirin is active in the fields of culture, health, FinTech, GovTech, BioTech, automotive, e-commerce, real estate and mobility. His entrepreneurial focus is on national and international companies and organizations that develop innovative ideas and solutions for social issues. He sees CELLphenomics as a pioneering factor in the further development of personalized cancer treatment. As a legal expert, he has been involved in the EU PRECODE project since 2019.